Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-31

Clinical Trial Update: Low and High Dose Zonisamide in Children as Monotherapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating low- and high-dose zonisamide as monotherapy in children with epilepsy. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonegran (zonisamide)

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Epilepsy | Phase 4 | Status: COMPLETED | Results posted: 2012-07-31